Can’t see any conflict of interest. But MSD has to make decisions on what’s working and what’s not. Clearly the combo didn’t cut the mustard.
Efti, on the other hand, has been FDA fast tracked with Keytruda in Head and Neck. And there’s good chance it might happen in the lung cancer trial too.
The disparity in mkt cap between Imm and Imu shows how irrational the market can be.
Media, page-201
-
- There are more pages in this discussion • 182 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
0.015(4.92%) |
Mkt cap ! $446.6M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 32.0¢ | 30.0¢ | $780.2K | 2.483M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 239610 | 31.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 141028 | 11 |
View Market Depth
| Last trade - 12.39pm 24/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |